MRNS
Marinus Pharmaceuticals Inc
Price:  
0.55 
USD
Volume:  
1,101,147.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS EV/EBITDA

-3462.2%
Upside

As of 2025-07-03, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.5x - 8.6x 8.1x
Forward P/E multiples 6.2x - 10.4x 8.4x
Fair Price (16.69) - (19.21) (18.49)
Upside -3135.2% - -3592.5% -3462.2%
0.55 USD
Stock Price
(18.49) USD
Fair Price

MRNS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA